Jeżuchowska Alicja, Cybulska Anna Maria, Rachubińska Kamila, Skonieczna-Żydecka Karolina, Reginia Artur, Panczyk Mariusz, Ćwiek Dorota, Grochans Elżbieta, Schneider-Matyka Daria
Department of Clinical Nursing, Wroclaw Medical University, 51-618 Wroclaw, Poland.
Department of Nursing, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.
Healthcare (Basel). 2024 Dec 9;12(23):2484. doi: 10.3390/healthcare12232484.
Mood disorders are among the most prevalent and debilitating mental conditions in worldwide populations. The aim of this study was to identify the factors influencing life satisfaction, disease acceptance, and therapeutic adherence among people with mood disorders. : This survey-based study included 103 people with mood disorders. It was performed using the author questionnaire, and standardized research tools, namely the Adherence to Refills and Medication Scale (ARMS), the Acceptance of Illness Scale (AIS), the Beck Depression Inventory (BDI), and the Satisfaction with Life Scale (SWLS). The level of life satisfaction decreased with the increase in the severity of the depressive symptoms ( = -0.665, < 0.001). Mood disorder patients with more severe depressive symptoms had significantly higher scores on the adherence scale ( = 0.290, = 0.003). The patients with higher levels of depressive symptoms showed a lower level of acceptance of the disease. 1. The dosage of medications taken, and the severity of the depressive symptoms determine life satisfaction of people with mood disorders. 2. The respondents with a greater severity of depressive symptoms scored higher on the adherence scale, which means that they were more likely to be non-adherent to the treatment recommendations. The type of mood disorder may affect patient adherence. The subjects with bipolar disorder showed higher adherence and those with anxiety-depressive disorder showed a lower adherence than the patients with depression. 3. The subjects with more severe depressive symptoms showed a lower degree of acceptance of the disease.
情绪障碍是全球人群中最普遍且使人衰弱的精神疾病之一。本研究的目的是确定影响情绪障碍患者生活满意度、疾病接受度和治疗依从性的因素。：这项基于调查的研究纳入了103名情绪障碍患者。研究使用了作者自编问卷以及标准化研究工具，即药物续用与服药依从性量表（ARMS）、疾病接受度量表（AIS）、贝克抑郁量表（BDI）和生活满意度量表（SWLS）。生活满意度水平随着抑郁症状严重程度的增加而降低（ = -0.665， < 0.001）。抑郁症状更严重的情绪障碍患者在依从性量表上的得分显著更高（ = 0.290， = 0.003）。抑郁症状水平较高的患者对疾病的接受度较低。1. 所服用药物的剂量以及抑郁症状的严重程度决定了情绪障碍患者的生活满意度。2. 抑郁症状更严重的受访者在依从性量表上得分更高，这意味着他们更有可能不遵循治疗建议。情绪障碍的类型可能会影响患者的依从性。双相情感障碍患者的依从性高于抑郁症患者，而焦虑抑郁障碍患者的依从性低于抑郁症患者。3. 抑郁症状更严重的受试者对疾病的接受程度较低。
